MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children
British Journal of Cancer 116, 990 (11 April 2017). doi:10.1038/bjc.2017.49
Authors: Veronica A Kinsler, Patricia O'Hare, Thomas Jacques, Darren Hargrave & Olga Slater
http://ift.tt/2m0JtOA
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου